Akorn, Inc. Enters into a Commercial Manufacturing Supply Agreement with Bioniche Pharma Ltd.

BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ: AKRX) a specialty pharmaceutical company and Bioniche Pharma have entered into a five-year commercial manufacturing and supply agreement for two undisclosed pharmaceutical products.